Lymphatic targeting for therapeutic application using nanoparticulate systems

References

• Ke X, Howard GP, Tang H, et al. Physical and chemical profiles of nanoparticles for lymphatic targeting. Adv Drug Deliv Rev. 2019;151–152:72–93.
   PubMed Web of Science ®Google Scholar
• Murfee WL, Breslin JW. Linking lymphatic function to disease. J Physiol. 2020;598(15):3065–3066.
   PubMed Web of Science ®Google Scholar
• Shukla R, Handa M, Pardhi VP. Introduction to pharmaceutical product development. In: Pharmaceutical drug product development and process optimization. New York: Apple Academic Press; 2020. p. 1–32.
   Google Scholar
• Jiang H, Wang Q, Sun X. Lymph node targeting strategies to improve vaccination efficacy. J Control Release. 2017;267:47–56.
   PubMed Web of Science ®Google Scholar
• Abellan-Pose R, Csaba N, Jose Alonso M. Lymphatic targeting of nanosystems for anticancer drug therapy. Curr Pharm Des. 2016;22(9):1194–1209.
   PubMed Web of Science ®Google Scholar
• Abdallah M, Müllertz OO, Styles IK, et al. Lymphatic targeting by albumin-hitchhiking: applications and optimisation. J Control Release. 2020;327:117–128.
   PubMed Web of Science ®Google Scholar
• Zhang F, Zarkada G, Yi S, et al. Lymphatic endothelial cell junctions: molecular regulation in physiology and diseases. Front Physiol. 2020;11:509.
   PubMed Web of Science ®Google Scholar
• Trevaskis NL, Kaminskas LM, Porter CJH. From sewer to saviour-targeting the lymphatic system to promote drug exposure and activity. Nat Rev Drug Discov. 2015;14(11):781–803.
   PubMed Web of Science ®Google Scholar
• Sheikh A, Md S, Kesharwani P. Aptamer grafted nanoparticle as targeted therapeutic tool for the treatment of breast cancer. Biomed Pharmacother. 2022;146:112530. https://linkinghub.elsevier.com/retrieve/pii/S0753332221013172.
   PubMed Web of Science ®Google Scholar
• Singh V, Md S, Alhakamy NA, et al. Taxanes loaded polymersomes as an emerging polymeric nanocarrier for cancer therapy. Eur Polym J. 2022;162:110883.
   Web of Science ®Google Scholar
• Choudhury H, Gorain B, Pandey M, et al. Surface engineering of nanoparticles for imparting multifunctionality. In: Nanoparticle therapeutics. UK: Academic Press; 2022. p. 181–210.
   Google Scholar
• Madamsetty VS, Tavakol S, Moghassemi S, et al. Chitosan: a versatile bio-platform for breast cancer theranostics. J Control Release. 2022;341:733–752. https://pubmed.ncbi.nlm.nih.gov/34906606/.
   PubMed Web of Science ®Google Scholar
• Sheikh A, Md S, Kesharwani P. RGD engineered dendrimer nanotherapeutic as an emerging targeted approach in cancer therapy. J Control Release. 2021;340:221–242. https://linkinghub.elsevier.com/retrieve/pii/S0168365921005824.
   PubMed Web of Science ®Google Scholar
• Mishra P, Handa M, Ujjwal RR, et al. Potential of nanoparticulate based delivery systems for effective management of alopecia. Colloids Surf B Biointerfaces. 2021;208:112050. https://linkinghub.elsevier.com/retrieve/pii/S092777652100494X.
   PubMed Web of Science ®Google Scholar
• Chadar R, Afzal O, Alqahtani SM, et al. Carbon nanotubes as an emerging nanocarrier for the delivery of doxorubicin for improved chemotherapy. Colloids Surf B Biointerfaces. 2021;208:112044. https://linkinghub.elsevier.com/retrieve/pii/S0927776521004884.
   PubMed Web of Science ®Google Scholar
• Gorantla S, Wadhwa G, Jain S, et al. Recent advances in nanocarriers for nutrient delivery. Drug Deliv Transl Res. 2021;29:1–26. https://pubmed.ncbi.nlm.nih.gov/34845678/.
   Google Scholar
• Kumar Bandaru R, Rout SR, Kenguva G, et al. Recent advances in pharmaceutical cocrystals: from bench to market. Front Pharmacol. 2021;12:1–16. https://pubmed.ncbi.nlm.nih.gov/34858194/.
   Web of Science ®Google Scholar
• Nitheesh Y, Pradhan R, Hejmady S, et al. Surface engineered nanocarriers for the management of breast cancer. Mater Sci Eng C Mater Biol Appl. 2021;130:112441.
   PubMed Web of Science ®Google Scholar
• Srivastava S, Mahor A, Singh G, et al. Formulation development, in vitro and in vivo evaluation of topical hydrogel formulation of econazole nitrate-loaded β-cyclodextrin nanosponges. J Pharm Sci. 2021;110(11):3702–3714. https://linkinghub.elsevier.com/retrieve/pii/S0022354921003646.
   Google Scholar
• Singh V, Kesharwani P. Recent advances in microneedles-based drug delivery device in the diagnosis and treatment of cancer. J Control Release. 2021;338:394–409. https://linkinghub.elsevier.com/retrieve/pii/S0168365921004685.
   PubMed Web of Science ®Google Scholar
• Sheikh A, Kesharwani P. An insight into aptamer engineered dendrimer for cancer therapy. Eur Polym J. 2021;159:110746. https://linkinghub.elsevier.com/retrieve/pii/S0014305721004808.
   Web of Science ®Google Scholar
• Singh A, Handa M, Ruwali M, et al. Nanocarrier mediated autophagy: an emerging trend for cancer therapy. Process Biochem. 2021;109:198–206. https://linkinghub.elsevier.com/retrieve/pii/S1359511321002233.
   Web of Science ®Google Scholar
• Kaur H, Kesharwani P. Advanced nanomedicine approaches applied for treatment of skin carcinoma. J Control Release. 2021;337:589–611. https://linkinghub.elsevier.com/retrieve/pii/S0168365921004028.
   PubMed Web of Science ®Google Scholar
• Singh V, Sahebkar A, Kesharwani P. Poly (propylene imine) dendrimer as an emerging polymeric nanocarrier for anticancer drug and gene delivery. Eur Polym J. 2021;158:110683. https://linkinghub.elsevier.com/retrieve/pii/S0014305721004171.
   Web of Science ®Google Scholar
• Chadar R, Afsana, Kesharwani P. Nanotechnology-based siRNA delivery strategies for treatment of triple negative breast cancer. Int J Pharm. 2021;605:120835. https://linkinghub.elsevier.com/retrieve/pii/S0378517321006402.
   PubMedGoogle Scholar
• Feng X, Xu W, Li Z, et al. Immunomodulatory nanosystems. Adv Sci (Weinh). 2019;6(17):1900101.
   PubMedGoogle Scholar
• Bouta EM, Bell RD, Rahimi H, et al. Targeting lymphatic function as a novel therapeutic intervention for rheumatoid arthritis. Nat Rev Rheumatol. 2018;14(2):94–106.
   PubMed Web of Science ®Google Scholar
• Singh A, Vaishagya K, K. Verma R, et al. Temperature/pH-triggered PNIPAM-based smart nanogel system loaded with anastrozole delivery for application in cancer chemotherapy. AAPS PharmSciTech. 2019;20(5):1–14. 10.1208/s12249-019-1410-3.
   Web of Science ®Google Scholar
• Luo G, Yu X, Jin C, et al. LyP-1-conjugated nanoparticles for targeting drug delivery to lymphatic metastatic tumors. Int J Pharm. 2010;385(1–2):150–156.
   PubMed Web of Science ®Google Scholar
• Charman WN, Stella VJ. Lymphatic transport of drugs. In: Lymphatic transport of drugs. Boca Raton: CRC Press; 2019.
   Google Scholar
• Zhang J, Lin Y, Lin Z, et al. Stimuli-responsive nanoparticles for controlled drug delivery in synergistic cancer immunotherapy. Adv Sci. 2022;9(5):2103444.
   Web of Science ®Google Scholar
• Patel P, Patel M. Enhanced oral bioavailability of nintedanib esylate with nanostructured lipid carriers by lymphatic targeting: in vitro, cell line and in vivo evaluation. Eur J Pharm Sci. 2021;159:105715.
   PubMed Web of Science ®Google Scholar
• Martin JT, Hartwell BL, Kumarapperuma SC, et al. Combined PET and whole-tissue imaging of lymphatic-targeting vaccines in non-human primates. Biomaterials. 2021;275:120868.
   PubMed Web of Science ®Google Scholar
• Pandya P, Giram P, Bhole RP, et al. Nanocarriers based oral lymphatic drug targeting: strategic bioavailability enhancement approaches. J Drug Deliv Sci Technol. 2021;64:102585.
   Web of Science ®Google Scholar
• Rizk SA, Elsheikh MA, Elnaggar YS, et al. Novel bioemulsomes for baicalin oral lymphatic targeting: development, optimization and pharmacokinetics. Nanomedicine (Lond). 2021;16(22):1983–1998.
   PubMed Web of Science ®Google Scholar
• Achen MG, Stacker SA. Molecular control of lymphatic metastasis. Ann N Y Acad Sci. 2008;1131(1):225–234.
   PubMedGoogle Scholar
• Kaur CD, Nahar M, Jain NK. Lymphatic targeting of zidovudine using surface-engineered liposomes. J Drug Target. 2008;16(10):798–805.
   PubMed Web of Science ®Google Scholar
• Kim J, Archer PA, Thomas SN. Innovations in lymph node targeting nanocarriers. Semin Immunol. 2021;56:101534.
   PubMed Web of Science ®Google Scholar
• Elz AS, Trevaskis NL, Porter CJ, et al. Smart design approaches for orally administered lipophilic prodrugs to promote lymphatic transport. J Control Release. 2022;341:676–701.
   PubMed Web of Science ®Google Scholar
• Han S, Mei L, Quach T, et al. Lipophilic conjugates of drugs: a tool to improve drug pharmacokinetic and therapeutic profiles. Pharm Res. 2021;38(9):1497–1518.
   PubMed Web of Science ®Google Scholar
• Mattheolabakis G, Milane L, Singh A, et al. Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine. J Drug Target. 2015;23(7–8):605–618.
   PubMed Web of Science ®Google Scholar
• Yan Z, Wang F, Wen Z, et al. LyP-1-conjugated PEGylated liposomes: a carrier system for targeted therapy of lymphatic metastatic tumor. J Control Release. 2012;157(1):118–125.
   PubMed Web of Science ®Google Scholar
• Coppi G, Iannuccelli V. Alginate/chitosan microparticles for tamoxifen delivery to the lymphatic system. Int J Pharm. 2009;367(1–2):127–132.
   PubMedGoogle Scholar
• Sinha R, Kim GJ, Nie S, et al. Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery. Mol Cancer Ther. 2006;5(8):1909–1917.
   PubMed Web of Science ®Google Scholar
• Ding Y, Li Z, Jaklenec A, et al. Vaccine delivery systems toward lymph nodes. Adv Drug Deliv Rev. 2021;179:113914.
   PubMed Web of Science ®Google Scholar
• Derlin T, Schultze-Florey C, Werner RA, et al. 18F-FDG PET/CT of off-target lymphoid organs in CD19-targeting chimeric antigen receptor T-cell therapy for relapsed or refractory diffuse large B-cell lymphoma. Ann Nucl Med. 2021;35(1):132–138.
   PubMed Web of Science ®Google Scholar
• Saraf S, Ghosh A, Kaur CD, et al. Novel modified nanosystem based lymphatic targeting. Res J Nanosci Nanotechnol. 2011;1(2):60–74.
   Google Scholar
• Moghimi SM. Nanoparticle engineering for the lymphatic system and lymph node targeting. RSC Nanosci Nanotechnol. 2010;10:81–97.
   Google Scholar
• Wang P, Zhang L, Peng H, et al. The formulation and delivery of curcumin with solid lipid nanoparticles for the treatment of on non-small cell lung cancer both in vitro and in vivo. Mater Sci Eng C. 2013;33(8):4802–4808.
   PubMed Web of Science ®Google Scholar
• Gadhave DG, Tagalpallewar AA, Kokare CR. Agranulocytosis-protective olanzapine-loaded nanostructured lipid carriers engineered for CNS delivery: optimization and hematological toxicity studies. AAPS PharmSciTech. 2019;20(1):22.
   PubMed Web of Science ®Google Scholar
• Vishwakarma N, Jain A, Sharma R, et al. Lipid-based nanocarriers for lymphatic transportation. AAPS PharmSciTech. 2019;20(2):1–3.
   Web of Science ®Google Scholar
• Gurumukhi VC, Bari SB. Quality by design (QbD)–based fabrication of atazanavir-loaded nanostructured lipid carriers for lymph targeting: bioavailability enhancement using chylomicron flow block model and toxicity studies. Drug Deliv Transl Res. 2021;12(5):1–23.
   Web of Science ®Google Scholar
• Üner M, Yener G. Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspective. Int J Nanomed. 2007;2(3):289–300.
   PubMed Web of Science ®Google Scholar
• Wissing SA, Kayser O, Müller RH. Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev. 2004;56(9):1257–1272.
   PubMed Web of Science ®Google Scholar
• Song T, Xia Y, Du Y, et al. Engineering the deformability of albumin-stabilized emulsions for lymph-node vaccine delivery. Adv Mater. 2021;33(26):2100106.
   Web of Science ®Google Scholar
• Almeida AJ, Souto E. Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Adv Drug Delivery Rev. 2007;59(6):478–490.
   PubMed Web of Science ®Google Scholar
• Dwivedi P, Khatik R, Khandelwal K, et al. Preparation and characterization of solid lipid nanoparticles of antimalarial drug arteether for oral administration. J Biomater Tissue Eng. 2014;4(2):133–137.
   Web of Science ®Google Scholar
• Truzzi E, Bongio C, Sacchetti F, et al. Self-assembled lipid nanoparticles for oral delivery of Heparin-coated iron oxide nanoparticles for theranostic purposes. Mol A J Synth Chem Nat Prod Chem. 2017;22(6):963–980.
   Google Scholar
• Cho H-J, Park JW, Yoon I-S, et al. Surface-modified solid lipid nanoparticles for oral delivery of docetaxel: enhanced intestinal absorption and lymphatic uptake. Int J Nanomed. 2014;9(1):495–504.
   PubMed Web of Science ®Google Scholar
• Harivardhan Reddy L, Sharma RK, Chuttani K, et al. Influence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton’s lymphoma tumor bearing mice. J Control Release. 2005;105(3):185–198.
   PubMed Web of Science ®Google Scholar
• Paliwal R, Rai S, Vaidya B, et al. Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery. Nanomedicine. 2009;5(2):184–191.
   PubMed Web of Science ®Google Scholar
• Zara GP, Bargoni A, Cavalli R, et al. Pharmacokinetics and tissue distribution of idarubicin-loaded solid lipid nanoparticles after duodenal administration to rats. J Pharm Sci. 2002;91(5):1324–1333.
   PubMed Web of Science ®Google Scholar
• Videira M, Almeida AJ, Fabra A. Preclinical evaluation of a pulmonary delivered paclitaxel-loaded lipid nanocarrier antitumor effect. Nanomedicine. 2012;8(7):1208–1215.
   PubMed Web of Science ®Google Scholar
• Garg NK, Sharma G, Singh B, et al. Quality by design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): an improved dermatokinetic profile for inflammatory disorder(s). Int J Pharm. 2017;517(1–2):413–431.
   PubMed Web of Science ®Google Scholar
• Tripathi P, Verma A, Dwivedi P, et al. Formulation and characterization of amphotericin B loaded nanostructured lipid carriers using microfluidizer. J Biomater Tissue Eng. 2014;4(3):194–197.
   Web of Science ®Google Scholar
• Zhuang CY, Li N, Wang M, et al. Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability. Int J Pharm. 2010;394(1–2):179–185.
   PubMed Web of Science ®Google Scholar
• Zhou L, Chen Y, Zhang Z, et al. Preparation of tripterine nanostructured lipid carriers and their absorption in rat intestine. Pharmazie. 2012;67(4):304–310.
   PubMed Web of Science ®Google Scholar
• Jawahar N, Hingarh PK, Radhakrishnan A, et al. Enhanced oral bioavailability of an antipsychotic drug through nanostructured lipid carriers. Int J Biol Macromol. 2018;110:269–275.
   PubMed Web of Science ®Google Scholar
• Khan S, Ganguli M, Aditya A, et al. Improved in vivo performance and immunomodulatory effect of novel omega-3 fatty acid based tacrolimus nanostructured lipid carrier. J Drug Deliv Sci Technol. 2019;52:138–149.
   Web of Science ®Google Scholar
• Chaudhary S, Garg T, Murthy RSR, et al. Recent approaches of lipid-based delivery system for lymphatic targeting via oral route. J Drug Target. 2014;22(10):871–882.
   PubMed Web of Science ®Google Scholar
• Oussoren C, Storm G. Liposomes to target the lymphatics by subcutaneous administration. Adv Drug Deliv Rev. 2001;50(1–2):143–156.
   PubMed Web of Science ®Google Scholar
• Ahn H, Park JH. Liposomal delivery systems for intestinal lymphatic drug transport. Biomater Res. 2016;20(1):1–6.
   PubMedGoogle Scholar
• Basu MK. Liposomal delivery of antileishmanial agents. J Appl Res. 2005;5(1):221–236.
   Google Scholar
• Ahmed KS, Hussein SA, Ali AH, et al. Liposome: composition, characterisation, preparation, and recent innovation in clinical applications [internet]. J Drug Target. 2019;27(7):742–761. 10.1080/1061186X.2018.1527337.
   PubMed Web of Science ®Google Scholar
• Ling SS, Magosso E, Khan NA, et al. Enhanced oral bioavailability and intestinal lymphatic transport of a hydrophilic drug using liposomes. Drug Dev Ind Pharm. 2006;32(3):335–345.
   PubMed Web of Science ®Google Scholar
• Tiantian Y, Wenji Z, Mingshuang S, et al. Study on intralymphatic-targeted hyaluronic acid-modified nanoliposome: influence of formulation factors on the lymphatic targeting. Int J Pharm. 2014;471(1–2):245–257.
   PubMedGoogle Scholar
• Feng L, Zhang L, Liu M, et al. Roles of dextrans on improving lymphatic drainage for liposomal drug delivery system. J Drug Target. 2010;18(3):168–178.
   PubMed Web of Science ®Google Scholar
• Yan Z, Zhan C, Wen Z, et al. LyP-1-conjugated doxorubicin-loaded liposomes suppress lymphatic metastasis by inhibiting lymph node metastases and destroying tumor lymphatics. Nanotechnology. 2011;22(41):415103.
   PubMed Web of Science ®Google Scholar
• Brigger I, Dubernet C, Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev. 2002;54(5):631–651.
   PubMed Web of Science ®Google Scholar
• Handa M, Sharma A, Verma RK, et al. Polycaprolactone based nano-carrier for co-administration of moxifloxacin and rutin and its in-vitro evaluation for sepsis. J Drug Deliv Sci Technol. 2019.
   Web of Science ®Google Scholar
• Shukla R, Handa M, Lokesh SB, et al. Conclusion and future prospective of polymeric nanoparticles for cancer therapy. In: Polymeric nanoparticles as a promising tool for anti-cancer therapeutics. London: Academic Press; 2019. p. 389–408.
   Google Scholar
• Soppimath KS, Aminabhavi TM, Kulkarni AR, et al. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release. 2001;70(1–2):1–20.
   PubMed Web of Science ®Google Scholar
• Liu J, Wong HL, Moselhy J, et al. Targeting colloidal particulates to thoracic lymph nodes. Lung Cancer. 2006;51(3):377–386.
   PubMed Web of Science ®Google Scholar
• Nam HY, Min KH, Kim DE, et al. Mussel-inspired poly(L-DOPA)-templated mineralization for calcium phosphate-assembled intracellular nanocarriers. Colloids Surf B Biointerfaces. 2017;157:215–222.
   PubMed Web of Science ®Google Scholar
• Li Y, Jin M, Shao S, et al. Small-sized polymeric micelles incorporating docetaxel suppress distant metastases in the clinically-relevant 4T1 mouse breast cancer model. BMC Cancer. 2014;14(1):329.
   PubMedGoogle Scholar
• Ryan GM, McLeod VM, Mehta D, et al. Lymphatic transport and lymph node targeting of methotrexate-conjugated PEGylated dendrimers are enhanced by reducing the length of the drug linker or masking interactions with the injection site. Nanomedicine. 2017;13(8):2485–2494.
   PubMed Web of Science ®Google Scholar
• Nishimoto Y, Nagashima S, Nakajima K, et al. Carboxyl-, sulfonyl-, and phosphate-terminal dendrimers as a nanoplatform with lymph node targeting. Int J Pharm. 2020;576:119021.
   PubMedGoogle Scholar
• Nishimoto Y, Nishio M, Nagashima S, et al. Association of hydrophobic carboxyl-terminal dendrimers with lymph node-resident lymphocytes. Polym. 2020;12(7):1474.
   Web of Science ®Google Scholar
• Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces. 2010;75(1):1–18.
   PubMed Web of Science ®Google Scholar
• Wu W, Wang Y, Que L. Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system. Eur J Pharm Biopharm. 2006;63(3):288–294.
   PubMed Web of Science ®Google Scholar
• Zhang P, Liu Y, Feng N, et al. Preparation and evaluation of self-microemulsifying drug delivery system of oridonin. Int J Pharm. 2008;355(1–2):269–276. http://www.ncbi.nlm.nih.gov/pubmed/18242895.
   PubMed Web of Science ®Google Scholar
• Shen H, Zhong M. Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin. J Pharm Pharmacol. 2006;58(9):1183–1191. http://www.ncbi.nlm.nih.gov/pubmed/16945176.
   PubMed Web of Science ®Google Scholar
• Cui J, Yu B, Zhao Y, et al. Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems. Int J Pharm. 2009;371(1–2):148–155.
   PubMed Web of Science ®Google Scholar
• Pokale R, Bandivadekar M. Self Micro-Emulsifying drug delivery system for lymphatic uptake of darunavir. J Drug Discov Dev Deliv. 2016;3(2):1–7.
   Google Scholar
• Singh G, Pai RS. Trans-resveratrol self-nano-emulsifying drug delivery system (SNEDDS) with enhanced bioavailability potential: optimization, pharmacokinetics and in situ single pass intestinal perfusion (SPIP) studies. Drug Deliv. 2015;22(4):522–530.
   PubMed Web of Science ®Google Scholar
• Garg B, Katare OP, Beg S, et al. Systematic development of solid self-nanoemulsifying oily formulations (S-SNEOFs) for enhancing the oral bioavailability and intestinal lymphatic uptake of lopinavir. Colloids Surf B Biointerfaces. 2016;141:611–622.
   PubMed Web of Science ®Google Scholar
• Dou YX, Zhou JT, Wang TT, et al. Self-nanoemulsifying drug delivery system of bruceine D: a new approach for anti-ulcerative colitis. Int J Nanomed. 2018;13:5887–5907.
   PubMed Web of Science ®Google Scholar
• Singh SK, Banala VT, Gupta GK, et al. Development of docetaxel nanocapsules for improving in vitro cytotoxicity and cellular uptake in MCF-7 cells. Drug Dev Ind Pharm. 2015;41(11):1759–1768.
   PubMed Web of Science ®Google Scholar
• Pardhi VP, Verma T, Flora SJS, et al. Nanocrystals: an overview of fabrication, characterization and therapeutic applications in drug delivery. Curr Pharm Des. 2019;24(43):5129–5146.
   Web of Science ®Google Scholar
• Huynh NT, Passirani C, Saulnier P, et al. Lipid nanocapsules: a new platform for nanomedicine. Int J Pharm. 2009;379(2):201–209.
   PubMed Web of Science ®Google Scholar
• Abellan-Pose R, Teijeiro-Valiño C, Santander-Ortega MJ, et al. Polyaminoacid nanocapsules for drug delivery to the lymphatic system: effect of the particle size. Int J Pharm. 2016;509(1–2):107–117.
   PubMedGoogle Scholar
• Shukla R, Kumar J, Dwivedi P, et al. Microparticles of diethylcarbamazine citrate for the treatment of lymphatic filariasis. Asian J Chem. 2013;25(Supp):S302.
   Google Scholar
• Yang D, Yang F, Hu J, et al. Hydrophilic multi-walled carbon nanotubes decorated with magnetite nanoparticles as lymphatic targeted drug delivery vehicles. Chem Commun. 2009;29:4447–4449.
   PubMed Web of Science ®Google Scholar
• Goel S, Mishra P. Thymoquinone loaded mesoporous silica nanoparticles retard cell invasion and enhance in vitro cytotoxicity due to ROS mediated apoptosis in HeLa and MCF-7 cell lines. Mater Sci Eng C Mater Biol Appl. 2019;104:109881–109891.
   PubMed Web of Science ®Google Scholar
• Dong X, Sun Z, Wang X, et al. Simultaneous monitoring of the drug release and antitumor effect of a novel drug delivery system-MWCNTs/DOX/TC. Drug Deliv. 2017;24(1):143–151.
   PubMed Web of Science ®Google Scholar
• Shukla R, Gupta J, Shukla P, et al. Chitosan coated alginate micro particles for the oral delivery of antifilarial drugs and combinations for intervention in Brugia malayi induced lymphatic filariasis. RSC Adv. 2015;5(85):69047–69056.
   Web of Science ®Google Scholar
• Singh I, Swami R, Khan W, et al. Lymphatic system: a prospective area for advanced targeting of particulate drug carriers. In Handbook of immunological properties of engineered nanomaterials. 2nd ed. Singapore: World Scientific Publishing Co. Pte. Ltd.; 2016. p. 363–398.
   Google Scholar
• Muranishi S. Drug targeting towards the lymphatics. Adv Drug Res. London: Academic Press; 1991. p. 1–38.
   Google Scholar
• Greish K. Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting. Methods Mol Biol. 2010;624:25–37.
   PubMedGoogle Scholar
• Jain V, Singodia D, Gupta GK, et al. Ciprofloxacin surf-plexes in Sub-micron emulsions: a novel approach to improve payload efficiency and antimicrobial efficacy. Int J Pharm. 2011;409(1–2):237–244.
   PubMedGoogle Scholar
• Gershenwald JE, Fidler IJ. Cancer: targeting lymphatic metastasis. Science. 2002;296(5574):1811–1812.
   PubMed Web of Science ®Google Scholar
• Khan AA, Mudassir J, Mohtar N, et al. Advanced drug delivery to the lymphatic system: lipid-based nanoformulations. Int J Nanomed. 2013;8:2733–2744.
   PubMed Web of Science ®Google Scholar
• Karaman S, Detmar M. Mechanisms of lymphatic metastasis. J Clin Invest. 2014;124(3):922–928.
   PubMed Web of Science ®Google Scholar
• Karajgi JS, Vyas SP. A lymphotropic colloidal carrier system for diethylcarbamazine: preparation and performance evaluation. J Microencapsul. 1994;11(5):539–545.
   PubMed Web of Science ®Google Scholar
• Shukla R, Mourya A, Handa M, et al. Role of nanomedicines in neglected tropical diseases. In: Nanopharmaceutical advanced delivery systems. USA: Scrivener Publishing LLC; 2021. p. 407–446.
   Google Scholar
• Hoerauf A. Filariasis: new drugs and new opportunities for lymphatic filariasis and onchocerciasis. Curr Opin Infect Dis. 2008;21(6):673–681.
   PubMed Web of Science ®Google Scholar
• Taylor MJ, Hoerauf A, Bockarie M. Lymphatic filariasis and onchocerciasis. Lancet. 2010;376(9747):1175–1185.
   PubMed Web of Science ®Google Scholar
• Bockarie MJ, Taylor MJ, Gyapong JO. Current practices in the management of lymphatic filariasis. Expert Rev Anti Infect Ther. 2009;7(5):595–605.
   PubMed Web of Science ®Google Scholar
• Mallipeddi R, Rohan LC. Progress in antiretroviral drug delivery using nanotechnology. Int J Nanomed. 2010;5:533–547.
   PubMed Web of Science ®Google Scholar
• Ando-Matsuoka R, Ando H, Lila AS, et al. Ip-injected cationic liposomes are retained and accumulate in peritoneally disseminated tumors. J Control Release. 2022;341:524–532.
   PubMed Web of Science ®Google Scholar
• Varma LT, Singh N, Gorain B, et al. Recent advances in self-assembled nanoparticles for drug delivery. Curr Drug Deliv. 2020;17(4):279–291.
   PubMed Web of Science ®Google Scholar
• Khan MI, Hossain MI, Hossain MK, et al. Recent progress in nanostructured smart drug delivery systems for cancer therapy: a review. ACS Appl Bio Mater. 2022;5(3):971–1012.
   PubMedGoogle Scholar
• Hossain MK, Khan MI, El-Denglawey A. A review on biomedical applications, prospects, and challenges of rare earth oxides. Appl Mater Today. 2021;24:101104.
   Web of Science ®Google Scholar
• Anik MI, Hossain MK, Hossain I, et al. Recent progress of magnetic nanoparticles in biomedical applications: a review. Nano Sel. 2021;2(6):1146–1186.
   Google Scholar
• Hossen S, Hossain MK, Basher MK, et al. Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: a review. J Adv Res. 2019;15:1–8.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Kawamoto S, Choyke PL, et al. Comparison of dendrimer-based macromolecular contrast agents for dynamic micro-magnetic resonance lymphangiography. Magn Reson Med. 2003;50(4):758–766.
   PubMed Web of Science ®Google Scholar
• Olmeda D, Cerezo-Wallis D, Castellano-Sanz E, et al. Physiological models for in vivo imaging and targeting the lymphatic system: nanoparticles and extracellular vesicles. Adv Drug Deliv Rev. 2021;175:113833.
   PubMed Web of Science ®Google Scholar